Literature DB >> 2551723

Coxsackievirus B3 myocarditis in C3H/HeJ mice: description of an inbred model and the effect of exercise on virulence.

R J Kiel1, F E Smith, J Chason, R Khatib, M P Reyes.   

Abstract

The effect of forced exercise on the development of coxsackievirus B3 myocarditis in inbred C3H/HeJ mice was studied. Four groups of mice (30 per group) were formed: infected-exercised (Group I); infected-unexercised (Group II); uninfected-exercised (Group III); and uninfected-unexercised (Group IV). Infected mice were inoculated intraperitoneally with 1.0 x 10(2.1) TCID50 coxsackievirus B3. Exercised animals were swum daily for 60 minutes on days 1-9. Myocardial viral titers were acutely elevated on day 3 of infection and were augmented significantly by exercise on days 6 and 9. Exercise increased the overall mortality from 0-10% to 20-40%; significantly increased heart: body weight ratios on days 6, 9 and 13; and increased the extent of myocardial fiber necrosis. We have reproduced the acceleration of CB3 myocarditis by exercise in the inbred C3H model.

Entities:  

Mesh:

Year:  1989        PMID: 2551723     DOI: 10.1007/BF00144836

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  4 in total

1.  COXSACKIE VIRUS B3 MYOCARDITIS IN MICE. AN ELECTRON MICROSCOPIC, IMMUNOFLUORESCENT AND VIRUS-ASSAY STUDY.

Authors:  E R RABIN; S A HASSAN; A B JENSON; J L MELNICK
Journal:  Am J Pathol       Date:  1964-05       Impact factor: 4.307

2.  Residual pathologic changes following murine coxsackie A and B myocarditis.

Authors:  F M Wilson; Q R Miranda; J L Chason; A M Lerner
Journal:  Am J Pathol       Date:  1969-05       Impact factor: 4.307

3.  Augmentation of the virulence of murine coxsackie-virus B-3 myocardiopathy by exercise.

Authors:  B G Gatmaitan; J L Chason; A M Lerner
Journal:  J Exp Med       Date:  1970-06-01       Impact factor: 14.307

4.  A mouse model of dilated-type cardiomyopathy due to coxsackievirus B3.

Authors:  M P Reyes; K L Ho; F Smith; A M Lerner
Journal:  J Infect Dis       Date:  1981-09       Impact factor: 5.226

  4 in total
  20 in total

Review 1.  Diagnosis, pathophysiology, and management of exercise-induced arrhythmias.

Authors:  Eduard Guasch; Lluís Mont
Journal:  Nat Rev Cardiol       Date:  2016-11-10       Impact factor: 32.419

Review 2.  Return to Activity After SARS-CoV-2 Infection: Cardiac Clearance for Children and Adolescents.

Authors:  Devyani Chowdhury; Michael A Fremed; Peter Dean; Julie S Glickstein; Jeff Robinson; Neil Rellosa; Deepika Thacker; David Soma; Susannah M Briskin; Chad Asplund; Jonathan Johnson; Christopher Snyder
Journal:  Sports Health       Date:  2021-08-24       Impact factor: 4.355

Review 3.  Viral Myocarditis: Classification, Diagnosis, and Clinical Implications.

Authors:  Fabiola B Sozzi; Elisa Gherbesi; Andrea Faggiano; Eleonora Gnan; Alessio Maruccio; Marco Schiavone; Laura Iacuzio; Stefano Carugo
Journal:  Front Cardiovasc Med       Date:  2022-06-20

4.  Antibody and CD8+ T cell memory response to influenza A/PR/8/34 infection is reduced in treadmill-exercised mice, yet still protective.

Authors:  Kristi Warren; Nicholas Thompson; Michael Wannemuehler; Marian Kohut
Journal:  J Appl Physiol (1985)       Date:  2013-03-14

5.  Chronic exercise reduces illness severity, decreases viral load, and results in greater anti-inflammatory effects than acute exercise during influenza infection.

Authors:  Young-Je Sim; Shan Yu; Kyoung-Jin Yoon; Kyoungjin J Yoon; Christie M Loiacono; Marian L Kohut
Journal:  J Infect Dis       Date:  2009-11-01       Impact factor: 5.226

Review 6.  Vaccination in elite athletes.

Authors:  Barbara C Gärtner; Tim Meyer
Journal:  Sports Med       Date:  2014-10       Impact factor: 11.136

7.  Pathophysiological Mechanisms by which Heat Stress Potentially Induces Kidney Inflammation and Chronic Kidney Disease in Sugarcane Workers.

Authors:  Erik Hansson; Jason Glaser; Kristina Jakobsson; Ilana Weiss; Catarina Wesseling; Rebekah A I Lucas; Jason Lee Kai Wei; Ulf Ekström; Julia Wijkström; Theo Bodin; Richard J Johnson; David H Wegman
Journal:  Nutrients       Date:  2020-06-02       Impact factor: 5.717

8.  Prevalence of Clinical and Subclinical Myocarditis in Competitive Athletes With Recent SARS-CoV-2 Infection: Results From the Big Ten COVID-19 Cardiac Registry.

Authors:  Curt J Daniels; Saurabh Rajpal; Joel T Greenshields; Geoffrey L Rosenthal; Eugene H Chung; Michael Terrin; Jean Jeudy; Scott E Mattson; Ian H Law; James Borchers; Richard Kovacs; Jeffrey Kovan; Sami F Rifat; Jennifer Albrecht; Ana I Bento; Lonnie Albers; David Bernhardt; Carly Day; Suzanne Hecht; Andrew Hipskind; Jeffrey Mjaanes; David Olson; Yvette L Rooks; Emily C Somers; Matthew S Tong; Jeffrey Wisinski; Jason Womack; Carrie Esopenko; Christopher J Kratochvil; Lawrence D Rink
Journal:  JAMA Cardiol       Date:  2021-05-27       Impact factor: 14.676

9.  Myopericarditis and exertional rhabdomyolysis following an influenza A (H3N2) infection.

Authors:  Guo-Shiang Tseng; Chung-Yueh Hsieh; Ching-Tsai Hsu; Jung-Chung Lin; Jenq-Shyong Chan
Journal:  BMC Infect Dis       Date:  2013-06-21       Impact factor: 3.090

10.  Diagnosis and management of viral myocarditis.

Authors:  William H Frishman; Joshua Zeidner; Nauman Naseer
Journal:  Curr Treat Options Cardiovasc Med       Date:  2007-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.